Redeye notes that AVTECH's reported figures aligned with its pre-announced results.
Redeye provides an initial comment on Safeture’s Q3 2025 report, where the company delivered a seque...
Redeye comments on Addnode’s Q3 report showing solid margins in PLM and PM.
Redeye provides its initial take on Lagercrantz’s Q2 2025/2026 report, which featured an EBITA that ...
Redeye states that the Q3 report showed continued strong growth, especially in the Wireless segment.
Redeye updates its view on Nanologica following what we view as an undramatic Q3 2025 report.
Redeye provides its initial take on Lifco’s Q3 2025 report, which aligned with our estimates.
Redeye comments on Hexatronic’s Q3 report, beating our expectations thanks to strong development in ...
Redeye is again making some positive adjustments to our forecasts on the back of encouraging Q3 numb...
Redeye reviews Alligator Bioscience’s Q3 report 2025.
While Fiskars' adjusted EBIT fell short of Modular Finance consensus, broad-based top-line growth is...
Redeye updates on Evolution after Q3 results that came in below expectations, owing to renewed weakn...
Redeye retains its positive view of Teneo AI following a Q3 with soft q/q ARR growth but solid momen...
* Small negative sales estimate revisions * Long term outlook is encouraging * Reiterate fair value ...
Redeye has a positive take on the news that Egetis has been granted a rolling NDA review based on cu...
Redeye’s outlook on Dynavox remains stable after another strong report.
* NOI -1% and rec PTP +2% vs ABGSCe * EC IFPM -3.4% q-o-q, partly due to cash position, ready for M&...
* Rec. PTP -4% vs ABGSCe * Occupancy flat q-o-q, as are values * Share to underperform the sector to...
* Q3 EBITDA NOK 14m vs ABGSCe NOK 9m * Awaiting stabilised markets * Only minor adjustments to estim...
Vaisala’s Q3’25 results were clearly better than estimated in terms of both revenue and profitabilit...
